Lanthanide(III) chelates as MRI contrast agents: A brief description

被引:14
|
作者
Rashid, H. Ur. [1 ]
Yu, K. [1 ]
Zhou, J. [1 ]
机构
[1] Huazhong Univ Sci & Technol, Sch Chem & Chem Engn, Wuhan 430074, Peoples R China
关键词
magnetic resonance imaging (MRI); gadolinium; relaxivity; nuclear relaxation; mean residence lifetime; contrast agents; hydration number; nephrogenic systemic fibrosis (NSF); NEPHROGENIC SYSTEMIC FIBROSIS; BLOOD-POOL AGENT; GADOLINIUM(III) COMPLEXES; WATER EXCHANGE; RELAXIVITY; RELAXATION; PHARMACOKINETICS; SENSITIVITY; STABILITY; CHEMISTRY;
D O I
10.1134/S002247661301037X
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
Magnetic resonance imaging (MRI) has become a prominent imaging technique in medicine. Gadoliniumbased contrast agents are extensively used to enhance the contrast between normal and diseased tissues through MRI scans. The article illustrates the paramount significance of such contrast agents in MRI applications. Clinically approved contrast agents as well as those in trial period are discussed. Important parameters, i.e. hydration number, rotational correlation time, and mean residence lifetime, influencing the relaxivity (sensitivity) of such agents are described in detail. Various approaches towards relaxivity enhancement are discussed with appropriate examples from the recent literature. A decrease in the Gdwater proton distance results in significant relaxivity enhancement. A comprehensive classification and explanation of Gd3+-based contrast agents are presented. Each class is explained with suitable examples. The stability of contrast agents is dependent on their chemical structure. Future contrast agents need to be tissue specific of high relaxivity, low toxicity, and lower administered dose for in vivo use.
引用
收藏
页码:223 / 249
页数:27
相关论文
共 50 条
  • [1] Lanthanide(III) chelates as MRI contrast agents: A brief description
    H. Ur. Rashid
    K. Yu
    J. Zhou
    Journal of Structural Chemistry, 2013, 54 : 223 - 249
  • [2] Kinetic stabilities of gadolinium(III) chelates used as MRI contrast agents
    Brücher, E
    CONTRAST AGENTS I: MAGNETIC RESONANCE IMAGING, 2002, 221 : 103 - 122
  • [3] Gadolinium(III) chelates as MRI contrast agents: Structure, dynamics, and applications
    Caravan, P
    Ellison, JJ
    McMurry, TJ
    Lauffer, RB
    CHEMICAL REVIEWS, 1999, 99 (09) : 2293 - 2352
  • [4] Lanthanide(III) complexation with ligands as possible contrast enhancing agents for MRI
    Choppin, GR
    Schaab, KM
    INORGANICA CHIMICA ACTA, 1996, 252 (1-2) : 299 - 310
  • [5] Lanthanide(III) complexation with ligands as possible contrast enhancing agents for MRI
    Florida State University, Department of Chemistry, Tallahassee, FL 32306-3006, United States
    Inorg. Chim. Acta, 1-2 (299-310):
  • [6] The Use of Molecular Descriptors in the Design of Gadolinium (III) Chelates as MRI Contrast Agents
    Maiocchi, Alessandro
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2003, 3 (08) : 845 - 859
  • [7] MRI CONTRAST AGENTS - MACROCYCLIC LANTHANIDE(III) COMPLEXES WITH IMPROVED RELAXATION EFFICIENCY
    AIME, S
    BOTTA, N
    CRICH, SG
    GIOVENZANA, GB
    JOMMI, G
    PAGLIARIN, R
    SISTI, M
    JOURNAL OF THE CHEMICAL SOCIETY-CHEMICAL COMMUNICATIONS, 1995, (18) : 1885 - 1886
  • [8] LANTHANIDE CHELATES AS MAGNETIC-RESONANCE IMAGING CONTRAST AGENTS
    SHERRY, AD
    JOURNAL OF THE LESS-COMMON METALS, 1989, 149 (1-2): : 133 - 141
  • [9] Synthesis and evaluation of a series of lanthanide chelates that act as T2ex MRI contrast agents
    Daryaei, Iman
    Moinpour, Mahta
    Pagel, Mark
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
  • [10] Structure-relaxivity study of glycopolymers containing gadolinium(III) chelates as MRI contrast agents
    Lucas, Robie L.
    Reineke, Theresa M.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233 : 612 - 612